Acute myeloid leukemia (AML) is a malignancy still associated with poor survival rates,
among others, due to frequent occurrence of therapy-resistant relapse after standard-of-care …

Parkinson's disease (PD) is a common age-related neurodegenerative disorder, which may
be largely due to the mitochondrial dysfunction and impaired mitophagy. Thus, it is of great …

Background Juvenile xanthogranuloma (JXG) is the most common non‐Langerhans cell
histiocytosis in children. The mortality and morbidity of JXG with extracutaneous lesions …

Background Acute myeloid leukemia (AML) is a heterogeneous disease that frequently
relapses after standard chemotherapy. Therefore, there is a need for the development of …

Simple Summary In this study, we generate an innovative endogenous progesterone
receptor (PR) reporter gene containing endometrial cancer cell lines and use this tool to …

Background: Recent evidence demonstrated that the treatment of acute myeloid leukemia
(AML) cells with daunorubicin (DNR) but not cytarabine (Ara-C) results in immunogenic cell …

Daunorubicin, also known as daunomycin, is a DNA‑targeting anticancer drug that is used
as chemotherapy, mainly for patients with leukemia. It has also been shown to have …

Mangiferin is a naturally occurring polyphenol, widely distributed in Thymeraceae families,
and presents pharmacological activity, including anti‐cancer activities in many human …

Despite significant advances in deciphering the molecular landscape of acute myeloid
leukaemia (AML), therapeutic outcomes of this haematological malignancy have only …

Introduction: Acute myeloid leukemia (AML) is a malignant proliferative disease affecting the
bone marrow hematopoietic system and has a poor long-term outcome. Exploring genes …